Literature DB >> 20965010

[Immunofluorescence mapping for diagnosis of congenital epidermolysis bullosa].

R Cepeda-Valdés1, G Pohla-Gubo, J R Borbolla-Escoboza, O Barboza-Quintana, J Ancer-Rodríguez, H Hintner, J C Salas-Alanis.   

Abstract

The tools for diagnosis of epidermolysis bullosa have advanced greatly since Hintner's group introduced antigen mapping as a diagnostic test for this family of genodermatoses. Monoclonal or polyclonal antibodies raised against some of the specific proteins found in the epidermis and basement membrane of the epidermis have allowed 4 types of epidermolysis bullosa de be identified and all variants to be classified. When a newborn baby presents with blisters, many conditions are implicated in the differential diagnosis. Examination under an optical microscope can suggest epidermolysis bullosa, but immunofluorescence mapping and electron microscopy are required for confirmation of the diagnosis and further classification of congenital epidermolysis bullosa. This article explains the importance of immunofluorescence antigen mapping and describes the methods employed for classification and subclassification of epidermolysis bullosa.

Mesh:

Year:  2010        PMID: 20965010

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  4 in total

1.  A case of a patient with severe epidermolysis bullosa surviving to adulthood.

Authors:  Amal R Hubail; Roza K Belkharoeva; Natalya P Tepluk; Olga V Grabovskaya
Journal:  Int J Gen Med       Date:  2018-11-15

2.  Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa.

Authors:  C Has; L Liu; M C Bolling; A V Charlesworth; M El Hachem; M J Escámez; I Fuentes; S Büchel; R Hiremagalore; G Pohla-Gubo; P C van den Akker; K Wertheim-Tysarowska; G Zambruno
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

3.  Utility of Immunofluorescence Antigen Mapping in Hereditary Epidermolysis Bullosa.

Authors:  Raghavendra Rao; Varsha M Shetty
Journal:  Indian J Dermatol       Date:  2021 Jul-Aug       Impact factor: 1.494

4.  Dystrophic Epidermolysis Bullosa.

Authors:  Randhir Sagar Yadav; Amar Jayswal; Shumneva Shrestha; Sanjay Kumar Gupta; Upama Paudel
Journal:  JNMA J Nepal Med Assoc       Date:  2018 Sep-Oct       Impact factor: 0.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.